Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial
Abstract Background Cardiovascular disease is the leading cause of mortality and morbidity worldwide, Chronic stable angina (CSA) is the main symptom of myocardial ischemia, causes increased risk of major cardiovascular events such as sudden cardiac death and myocardial infarction. Naoxintong (NXT)...
Main Authors: | Gao Huanjia, Cai Hairong, Zhuang Jieqin, Dai Xingzhen, Fu Xue, Zhang Weizhang, Chen Bojun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05264-y |
Similar Items
-
Specific DNA identification of Pheretima in the Naoxintong capsule
by: Xiaoxiao Zhu, et al.
Published: (2019-09-01) -
Protective effects of Naoxintong Capsule on rats with blood stasis syndrome
by: Wei-jian Zhang, et al.
Published: (2020-01-01) -
Effect of atorvastatin in combined with Naoxintong capsue on carotid atherosclerosis in patients with cerebral infarction
by: Cui Gu, et al.
Published: (2016-08-01) -
NaoXinTong Capsule ameliorates memory deficit in APP/PS1 mice by regulating inflammatory cytokines
by: Xuerui Wang, et al.
Published: (2021-01-01) -
Pharmacokinetics and biotransformation investigation in beagle dog of active compounds from naoxintong capsule
by: Yan He, et al.
Published: (2021-01-01)